Investigating the effects of synthetic drug combinations on users
Synthetics in Combination (SYNC)
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10862684
This study is looking into how people use synthetic drugs like fentanyl, methamphetamine, and benzodiazepines together, to better understand their experiences and the risks involved, so we can find better ways to help those affected by these drugs.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10862684 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the rising prevalence of synthetic drugs like fentanyls, methamphetamine, and benzodiazepines in the illicit drug market, particularly how they are used in combination. By employing ethnographic methods, the study aims to gather insights from individuals who use these drugs to explore their experiences, preferences, and the risks associated with polydrug use. Additionally, the research will analyze epidemiological data to assess the impact of these drug combinations on overdose fatalities and health outcomes. The goal is to uncover the complexities of drug use patterns and the motivations behind them, which could inform better prevention and intervention strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who actively use synthetic drugs, particularly those who have experience with polydrug use involving fentanyls, methamphetamine, and benzodiazepines.
Not a fit: Patients who do not use synthetic drugs or have no history of polydrug use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and strategies to reduce overdose fatalities associated with synthetic drug use.
How similar studies have performed: While the study addresses a critical and emerging area of drug use, similar research has shown that understanding polydrug use patterns can lead to significant insights into overdose prevention.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CICCARONE, DANIEL H — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: CICCARONE, DANIEL H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.